Funding for this research was provided by:
Daiichi-Sankyo
Article History
Accepted: 26 February 2024
First Online: 19 March 2024
Declarations
:
: This study was funded by Daiichi Sankyo.
: Kevin Wang is an employee of Daiichi Sankyo, Inc., Basking Ridge, NJ. Winghan Jacqueline Kwong and Peng Wang are former employees of Daiichi Sankyo, Inc. Ralph Boccia has been a consultant to AbbVie, Daiichi Sankyo/American Regent, and Bristol Myers Squibb and has served on speakers bureaus for AbbVie, Daiichi Sankyo/American Regent, Bristol Myers Squibb, Amgen, Incyte, Genentech, AstraZeneca, Regeneron, and Sanofi. Medical writing assistance, funded by Daiichi Sankyo, was provided by Peloton Advantage, LLC, an OPEN Health company, under the direction of the authors.
: The database used to conduct this study is available from IQVIA with a licensing agreement (). Sharing of data supporting the results reported in this article may be considered upon request by contacting kwang@dsi.com.
: This retrospective claims analysis utilized medical and pharmacy claims from the IQVIA PharMetrics Plus database (IQVIA, Durham, NC, USA), from 01/01/2017 to 31/12/2019. Data in the database are deidentified and compliant with the Health Insurance Portability and Accountability Act.
: Not applicable.
: Not applicable.
: Not applicable.
: Jackie Kwong, Kevin Wang, and Peng Wang designed the study. Jackie Kwong and Ralph Boccia served as study investigators. Kevin Wang collected, assembled, and analyzed the data. All authors interpreted the data, prepared the manuscript, reviewed and revised the manuscript, and provided final approval for publication.